Obesity and Breast Cancer

The Role of Dysregulated Estrogen Metabolism

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Endocrinology & Metabolism, Oncology
Cover of the book Obesity and Breast Cancer by Kristy A. Brown, Evan R. Simpson, Springer New York
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: Kristy A. Brown, Evan R. Simpson ISBN: 9781489980021
Publisher: Springer New York Publication: November 21, 2013
Imprint: Springer Language: English
Author: Kristy A. Brown, Evan R. Simpson
ISBN: 9781489980021
Publisher: Springer New York
Publication: November 21, 2013
Imprint: Springer
Language: English

Obesity is a risk factor for breast cancer in older women. A number of adipose-derived and obesity-related factors have been shown to affect tumour cell growth. These include adipokines, insulin, IGF-1 and oestrogens. The majority of obesity-related postmenopausal breast cancers are oestrogen-dependent. Since the ovaries no longer produce oestrogens after menopause, and that circulating levels are negligible, it is evident that it is the oestrogens produced locally within the breast adipose that are responsible for the increased growth of breast cancer cells. Aromatase is the enzyme that converts androgens into oestrogens and its regulation is dependent on the activity of a number of tissue-specific promoters. Targeting oestrogen biosynthesis in obesity may be useful for the prevention of breast cancer. Aromatase inhibitors are efficacious at treating postmenopausal breast cancer and recent studies suggest that they may also be useful in the prevention setting. However, these compounds inhibit the catalytic activity of aromatase and as a consequence lead to a number of undesirable side-effects, including arthralgia and possible cognitive defects due to inhibition of aromatase in the bone and brain, respectively. Novel therapies, such as those employed to treat obesity-associated disease, including anti-diabetics, may prove successful at inhibiting aromatase specifically within the breast. This SpringerBrief will explore all of these issues in depth and the authors are in a unique position to write about this topic, having extensive experience in the field of aromatase research.​

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Obesity is a risk factor for breast cancer in older women. A number of adipose-derived and obesity-related factors have been shown to affect tumour cell growth. These include adipokines, insulin, IGF-1 and oestrogens. The majority of obesity-related postmenopausal breast cancers are oestrogen-dependent. Since the ovaries no longer produce oestrogens after menopause, and that circulating levels are negligible, it is evident that it is the oestrogens produced locally within the breast adipose that are responsible for the increased growth of breast cancer cells. Aromatase is the enzyme that converts androgens into oestrogens and its regulation is dependent on the activity of a number of tissue-specific promoters. Targeting oestrogen biosynthesis in obesity may be useful for the prevention of breast cancer. Aromatase inhibitors are efficacious at treating postmenopausal breast cancer and recent studies suggest that they may also be useful in the prevention setting. However, these compounds inhibit the catalytic activity of aromatase and as a consequence lead to a number of undesirable side-effects, including arthralgia and possible cognitive defects due to inhibition of aromatase in the bone and brain, respectively. Novel therapies, such as those employed to treat obesity-associated disease, including anti-diabetics, may prove successful at inhibiting aromatase specifically within the breast. This SpringerBrief will explore all of these issues in depth and the authors are in a unique position to write about this topic, having extensive experience in the field of aromatase research.​

More books from Springer New York

Cover of the book Essentials of Water Systems Design in the Oil, Gas, and Chemical Processing Industries by Kristy A. Brown, Evan R. Simpson
Cover of the book Control of Violence by Kristy A. Brown, Evan R. Simpson
Cover of the book Risk Assessment and Evaluation of Predictions by Kristy A. Brown, Evan R. Simpson
Cover of the book Tabular Application Development for Information Systems by Kristy A. Brown, Evan R. Simpson
Cover of the book Systems Analysis of Human Multigene Disorders by Kristy A. Brown, Evan R. Simpson
Cover of the book The Mathematics and Mechanics of Biological Growth by Kristy A. Brown, Evan R. Simpson
Cover of the book The Rainbow Sky by Kristy A. Brown, Evan R. Simpson
Cover of the book Residue Reviews by Kristy A. Brown, Evan R. Simpson
Cover of the book Wafer-Level Chip-Scale Packaging by Kristy A. Brown, Evan R. Simpson
Cover of the book The Doomsday Lobby by Kristy A. Brown, Evan R. Simpson
Cover of the book R for Stata Users by Kristy A. Brown, Evan R. Simpson
Cover of the book Designing Public Procurement Policy in Developing Countries by Kristy A. Brown, Evan R. Simpson
Cover of the book Current Techniques in Neurosurgery by Kristy A. Brown, Evan R. Simpson
Cover of the book Contraception for Adolescent and Young Adult Women by Kristy A. Brown, Evan R. Simpson
Cover of the book Biogas Energy by Kristy A. Brown, Evan R. Simpson
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy